These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
597 related articles for article (PubMed ID: 19138391)
1. Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia. Lim P; Alker AP; Khim N; Shah NK; Incardona S; Doung S; Yi P; Bouth DM; Bouchier C; Puijalon OM; Meshnick SR; Wongsrichanalai C; Fandeur T; Le Bras J; Ringwald P; Ariey F Malar J; 2009 Jan; 8():11. PubMed ID: 19138391 [TBL] [Abstract][Full Text] [Related]
2. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine. Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998 [TBL] [Abstract][Full Text] [Related]
3. Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border. Alker AP; Lim P; Sem R; Shah NK; Yi P; Bouth DM; Tsuyuoka R; Maguire JD; Fandeur T; Ariey F; Wongsrichanalai C; Meshnick SR Am J Trop Med Hyg; 2007 Apr; 76(4):641-7. PubMed ID: 17426163 [TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine. Venkatesan M; Gadalla NB; Stepniewska K; Dahal P; Nsanzabana C; Moriera C; Price RN; Mårtensson A; Rosenthal PJ; Dorsey G; Sutherland CJ; Guérin P; Davis TME; Ménard D; Adam I; Ademowo G; Arze C; Baliraine FN; Berens-Riha N; Björkman A; Borrmann S; Checchi F; Desai M; Dhorda M; Djimdé AA; El-Sayed BB; Eshetu T; Eyase F; Falade C; Faucher JF; Fröberg G; Grivoyannis A; Hamour S; Houzé S; Johnson J; Kamugisha E; Kariuki S; Kiechel JR; Kironde F; Kofoed PE; LeBras J; Malmberg M; Mwai L; Ngasala B; Nosten F; Nsobya SL; Nzila A; Oguike M; Otienoburu SD; Ogutu B; Ouédraogo JB; Piola P; Rombo L; Schramm B; Somé AF; Thwing J; Ursing J; Wong RPM; Zeynudin A; Zongo I; Plowe CV; Sibley CH; Asaq Molecular Marker Study Group Am J Trop Med Hyg; 2014 Oct; 91(4):833-843. PubMed ID: 25048375 [TBL] [Abstract][Full Text] [Related]
5. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia. Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849 [TBL] [Abstract][Full Text] [Related]
6. Identification of resistance of Plasmodium falciparum to artesunate-mefloquine combination in an area along the Thai-Myanmar border: integration of clinico-parasitological response, systemic drug exposure, and in vitro parasite sensitivity. Na-Bangchang K; Muhamad P; Ruaengweerayut R; Chaijaroenkul W; Karbwang J Malar J; 2013 Jul; 12():263. PubMed ID: 23898808 [TBL] [Abstract][Full Text] [Related]
7. K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar. Win AA; Imwong M; Kyaw MP; Woodrow CJ; Chotivanich K; Hanboonkunupakarn B; Pukrittayakamee S Malar J; 2016 Feb; 15():110. PubMed ID: 26911145 [TBL] [Abstract][Full Text] [Related]
8. Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia. Rogers WO; Sem R; Tero T; Chim P; Lim P; Muth S; Socheat D; Ariey F; Wongsrichanalai C Malar J; 2009 Jan; 8():10. PubMed ID: 19138388 [TBL] [Abstract][Full Text] [Related]
9. Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. Sidhu AB; Uhlemann AC; Valderramos SG; Valderramos JC; Krishna S; Fidock DA J Infect Dis; 2006 Aug; 194(4):528-35. PubMed ID: 16845638 [TBL] [Abstract][Full Text] [Related]
10. A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand. Hutagalung R; Paiphun L; Ashley EA; McGready R; Brockman A; Thwai KL; Singhasivanon P; Jelinek T; White NJ; Nosten FH Malar J; 2005 Sep; 4():46. PubMed ID: 16179089 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola. Kiaco K; Teixeira J; Machado M; do Rosário V; Lopes D Malar J; 2015 Dec; 14():504. PubMed ID: 26670642 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia. Denis MB; Tsuyuoka R; Lim P; Lindegardh N; Yi P; Top SN; Socheat D; Fandeur T; Annerberg A; Christophel EM; Ringwald P Trop Med Int Health; 2006 Dec; 11(12):1800-7. PubMed ID: 17176344 [TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms of candidate markers and in vitro susceptibility of Plasmodium falciparum isolates from Thai-Myanmar border in relation to clinical response to artesunate-mefloquine combination. Phompradit P; Muhamad P; Chaijaroenkul W; Na-Bangchang K Acta Trop; 2014 Nov; 139():77-83. PubMed ID: 25004442 [TBL] [Abstract][Full Text] [Related]
15. Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007. Lim P; Wongsrichanalai C; Chim P; Khim N; Kim S; Chy S; Sem R; Nhem S; Yi P; Duong S; Bouth DM; Genton B; Beck HP; Gobert JG; Rogers WO; Coppee JY; Fandeur T; Mercereau-Puijalon O; Ringwald P; Le Bras J; Ariey F Antimicrob Agents Chemother; 2010 May; 54(5):2135-42. PubMed ID: 20194689 [TBL] [Abstract][Full Text] [Related]
16. Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda. Baraka V; Mavoko HM; Nabasumba C; Francis F; Lutumba P; Alifrangis M; Van Geertruyden JP PLoS One; 2018; 13(2):e0191922. PubMed ID: 29390014 [TBL] [Abstract][Full Text] [Related]
17. Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria. Price RN; Uhlemann AC; van Vugt M; Brockman A; Hutagalung R; Nair S; Nash D; Singhasivanon P; Anderson TJ; Krishna S; White NJ; Nosten F Clin Infect Dis; 2006 Jun; 42(11):1570-7. PubMed ID: 16652314 [TBL] [Abstract][Full Text] [Related]
18. Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemether-lumefantrine in Nigerian children with uncomplicated falciparum malaria. Happi CT; Gbotosho GO; Folarin OA; Sowunmi A; Hudson T; O'Neil M; Milhous W; Wirth DF; Oduola AM Antimicrob Agents Chemother; 2009 Mar; 53(3):888-95. PubMed ID: 19075074 [TBL] [Abstract][Full Text] [Related]
19. Association between the pfmdr1 gene and in vitro artemether and lumefantrine sensitivity in Thai isolates of Plasmodium falciparum. Mungthin M; Khositnithikul R; Sitthichot N; Suwandittakul N; Wattanaveeradej V; Ward SA; Na-Bangchang K Am J Trop Med Hyg; 2010 Nov; 83(5):1005-9. PubMed ID: 21036827 [TBL] [Abstract][Full Text] [Related]
20. Artemisinin resistance in Plasmodium falciparum malaria. Dondorp AM; Nosten F; Yi P; Das D; Phyo AP; Tarning J; Lwin KM; Ariey F; Hanpithakpong W; Lee SJ; Ringwald P; Silamut K; Imwong M; Chotivanich K; Lim P; Herdman T; An SS; Yeung S; Singhasivanon P; Day NP; Lindegardh N; Socheat D; White NJ N Engl J Med; 2009 Jul; 361(5):455-67. PubMed ID: 19641202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]